BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 29238019)

  • 1. [Inflammation and osteoclasts].
    Yokota K
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(5):367-376. PubMed ID: 29238019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [RANKL/RANK signaling in rheumatoid arthritis].
    Omata Y; Tanaka S
    Clin Calcium; 2011 Aug; 21(8):1175-80. PubMed ID: 21814022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclast differentiation in rheumatoid arthritis.
    Yokota K
    Immunol Med; 2024 Mar; 47(1):6-11. PubMed ID: 37309864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanisms of bone destruction in rheumatoid arthritis].
    Nanki T
    Clin Calcium; 2007 Apr; 17(4):510-6. PubMed ID: 17404479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
    Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synovial fluid macrophages are capable of osteoclast formation and resorption.
    Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
    J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
    Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
    J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [RANKL signaling and bone diseases. Quiescent osteoclast precursors and RANKL signaling].
    Mizoguchi T
    Clin Calcium; 2011 Aug; 21(8):1187-92. PubMed ID: 21814024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
    J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.
    Glantschnig H; Fisher JE; Wesolowski G; Rodan GA; Reszka AA
    Cell Death Differ; 2003 Oct; 10(10):1165-77. PubMed ID: 14502240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis.
    Udagawa N
    J Bone Miner Metab; 2003; 21(6):337-43. PubMed ID: 14586789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokine-mediated bone resorption].
    Nakamura M; Uehara S; Nakamura H; Udagawa N
    Clin Calcium; 2014 Jun; 24(6):837-44. PubMed ID: 24870834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo.
    Yokota K; Sato K; Miyazaki T; Kitaura H; Kayama H; Miyoshi F; Araki Y; Akiyama Y; Takeda K; Mimura T
    Arthritis Rheumatol; 2014 Jan; 66(1):121-9. PubMed ID: 24431283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
    Takahashi N; Udagawa N; Suda T
    Biochem Biophys Res Commun; 1999 Mar; 256(3):449-55. PubMed ID: 10080918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts.
    O' Gradaigh D; Ireland D; Bord S; Compston JE
    Ann Rheum Dis; 2004 Apr; 63(4):354-9. PubMed ID: 15020327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.
    Komano Y; Nanki T; Hayashida K; Taniguchi K; Miyasaka N
    Arthritis Res Ther; 2006; 8(5):R152. PubMed ID: 16987426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial macrophage-osteoclast differentiation in inflammatory arthritis.
    Danks L; Sabokbar A; Gundle R; Athanasou NA
    Ann Rheum Dis; 2002 Oct; 61(10):916-21. PubMed ID: 12228163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular understanding of osteoclast differentiation.
    Asagiri M; Takayanagi H
    Bone; 2007 Feb; 40(2):251-64. PubMed ID: 17098490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system.
    Tanaka S
    Am J Nephrol; 2007; 27(5):466-78. PubMed ID: 17652963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.